Company Financials
BioAtla, Inc. Financials
United States dollar
business
BioAtla, Inc. Company Profile
Main Stock Listing
NASDAQ: BCAB
Market Capitalization $28.5 Million as of Jan. 1, 2025
Market Cap History
Valuations Metrics as of May. 5, 2024
| Trailing PE | |
| Forward PE | -1.68 |
| Price to Sales TTM | $ |
| Price to Book MRQ | $2.21 |
| Enterprise to Revenue | |
| Enterprise to EBITDA | -0.37 |
Financial Reports as of Dec. 31, 2023
Financials
| Fiscal Year Ends | 2023-12-31 |
| Most Recent Quarter | 2023-12-31 |
| Profit Margin | 0.00% |
| Operating Margin | 0.00% |
| Return on Assets TTM | -46.93% |
| Return on Equity TTM | -98.37% |
Income Statement
| Revenue TTM | $0 |
| Revenue per Share TTM | $ |
| Quarterly Revenue Growth | % |
| Gross Profit TTM | $0 |
| EBITDA | $-128,466,000 |
| Net Income to Common TTM | $-123,462,000 |
| Diluted EPS TTM | $-2.58 |
| Quarterly Earnings Growth YoY | % |
Balance Sheet
| Total Cash MRQ | $111,471,000 |
| Total Cash per Share MRQ | $2.32 |
| Total Debt MRQ | $ |
| Total Debt to Equity MRQ | 3.48 |
| Current Ratio MRQ | 4.11 |
| Book Value per Share MRQ | $1.47 |
Cash Flow
| Operating Cash Flow TTM | $-104,015,000 |
| Levered Free Cash Flow TTM | $-61,288,376 |
BCAB Stock Info as of May. 5, 2024
Stock Statistics
| Shares Outstanding | 48,106,300 |
| Float Shares | 33,096,794 |
| Avg 10 Volume | 967,887 |
| Avg 30 Volume | None |
| Shares Short | 5,415,358 |
| Short Ratio | 7.48 |
| Short % of Shares | 12.59% |
| % Held by Insiders | 9.67% |
| % Held by Institutions | 64.66% |
Stock Price Summary
| Beta | 1.06 |
| Fifty Two Week Low | $1.24 |
| Fifty Two Week High | $4.07 |
| Fifty Two Week Change | -0.31% |
| Day 50 MA | $2.81 |
| Day 200 MA | $2.30 |
Dividends and Splits
| Forward Annual Dividend Rate | $ |
| Forward Annual Dividend Yield | % |
| Trailing Annual Dividend Rate | $0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Dividend Date | |
| Ex Dividend Date | |
| Last Split Factor | |
| Last Split Date |